This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
PlushCare para usuarios hispanohablantes
PlushCare ofrece consultas virtuales de atención primaria y evaluación de control de peso. Cuando corresponde, el profesional puede enviar una receta a una farmacia; la membresía, la consulta, los análisis y el medicamento pueden tener costes separados.
Su aviso de no discriminación ofrece asistencia lingüística gratuita, incluido español. Confirma al reservar si la cita concreta será con un profesional hispanohablante o mediante asistencia lingüística.
Aviso de idioma y accesibilidad de PlushCare ↗- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A general primary-care telehealth service where a board-certified physician can evaluate, prescribe, and monitor FDA-approved weight-management medications. Membership, visits, medication, and labs are separate cost layers.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)
- Formats reviewed
- Injection · Oral medicine
- Funding routes
- Private pay · Insurance support
- Service features
- Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 3 medicine rows · 4 open checks
Recurring cost breakdown
- PlushCare advertises a membership with a free introductory period; confirm the current recurring membership at enrollment.
- Initial and follow-up medical visits are charged separately or billed to participating insurance.
- Medication and laboratory charges are separate.
- The final cost depends on network status, visit frequency, pharmacy benefit, and medication selected.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Wegovy / Zepbound | Weekly injection | FDA-approved for weight management | Pharmacy cash price or insurance copay |
| Ozempic / Mounjaro / Rybelsus / Victoza | Oral or injectable | FDA-approved for type 2 diabetes | Indication and coverage dependent |
| Saxenda | Daily injection | FDA-approved for weight management | Pharmacy cash price or insurance copay |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Same-day virtual appointments are advertised seven days a week across a broad US footprint.
- Clinician licensure and medication access remain state-specific.
Clinician access and follow-up cadence
- Board-certified primary-care physicians conduct visits and ongoing medication management.
- Follow-up frequency is determined by the physician and prescription needs, not a bundled fixed program calendar.
Pharmacy and fulfillment
- Prescriptions are sent to the patient’s chosen or covered retail pharmacy.
- Medication is not represented as a PlushCare-bundled shipment.
Insurance and prior authorization
- PlushCare accepts many insurance plans for visits and can support prescriptions.
- Medical-visit network status does not establish pharmacy-benefit coverage; prior authorization and copay are separate.
Cancellation, refund, and commitment
- Membership cancellation does not cancel scheduled visits or pharmacy prescriptions automatically.
- Confirm visit cancellation windows and membership renewal separately.
Labs, monitoring, and dose management
- A physician may order labs through ordinary laboratory channels.
- Labs are separate from membership and medication price.
Maintenance and switching
- Primary-care clinicians may consider refills or continuation after evaluating records.
- Send the medication, dose, indication, last fill, and recent labs before assuming continuity.
Program snapshot
Virtual-care membership and visits
Profiled support: Ongoing clinician access.
Cash pay · Insurance help
PlushCare accepts many insurance plans, but participation and medication benefits are separate checks.
Verify before purchase
Prescriptions are generally sent to a pharmacy rather than bundled with the membership.
What the advertised program may include
- Virtual clinician appointments
- Broader primary-care access
- Prescription routing when appropriate
- Insurance billing on eligible visits
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- One all-in recurring total
- Guaranteed prior-authorization timeline
- State-by-product table
- Fixed follow-up cadence
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Medication menu, physician model and appointment access
Membership and visit-cost structure